EXPRESSION

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2014-11-10 for EXPRESSION manufactured by Enhancement Medical.

Event Text Entries

[20322711] On (b)(6) 2014 i was injected with expression in both cheek areas as a wrinkle reducer by dr. (b)(6) 9a board certified plastic surgeon. I have never used this product before. Within a few days my cheek bone area became swollen and red, itchy and hard especially, my left side. The swelling increased daily. I called his office on (b)(6). He was away and his staff contacted him and he advised warm compresses. On (b)(6) the left side facial swelling was so bad my eye was almost closed. I went to an emergency room and was diagnosed with cellulitis not an allergic reaction but yet prescribed 500 mg of keflex. Prior to my injection i was told by dr. (b)(6) that the expression was not fda approved just as most injectables were not. At my recent visit he told me that i was only the third person to have a reaction. The keflex seems to be working as well and the swelling has diminished slightly especially around the eye areas.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5039089
MDR Report Key4254833
Date Received2014-11-10
Date of Report2014-11-10
Date of Event2014-10-29
Date Added to Maude2014-11-18
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Reporter OccupationPATIENT
Health Professional0
Initial Report to FDA3
Report to FDA0
Event Location0
Single Use0
Previous Use Code0
Event Type3
Type of Report3

Device Details

Brand NameEXPRESSION
Generic NameWRINKLE REDUCER
Product CodeOHS
Date Received2014-11-10
Device Sequence No1
Device Event Key0
ManufacturerENHANCEMENT MEDICAL


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2014-11-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.